FGF gene expression in injured tendons as a prognostic biomarker of 1-year patient outcome after Achilles tendon repair

• Main Authors: Junyu Chen, Joel Svensson, Carl-Johan Sundberg, Aisha Siddiqah Ahmed, Paul W. Ackermann
• Format: Article
• Language: English
• Published: SpringerOpen 2021-03-01
• Series: Journal of Experimental Orthopaedics
• Subjects: Achilles tendon rupture; Patient outcome; Biomarkers; mRNA expression, immunohistochemistry
• Online Access: https://doi.org/10.1186/s40634-021-00335-0

Abstract Purpose Healing outcome after Achilles Tendon Rupture (ATR) is variable and unsatisfactory. Many ATR patients still exhibit pain, functional deficits and limitations in walking one-year post-surgery. The present study was designed to investigate the association between the expression of healing biomarkers and patient outcome after ATR. Methods Tendon biopsies were collected from 25 ATR patients during surgery. At 1-year post surgery, all patients completed questionnaires; Achilles tendon Total Rupture Score (ATRS) and Foot and Ankle Outcome Score (FAOS), and were tested for functional outcomes by heel-rise test. In biopsies, FGF, COL III, FN, COL I and MMP-9 mRNA levels were assessed by quantitative RT-PCR while protein expression was studied by immunohistochemistry (IHC). Results Our analysis confirmed the presence of FGF, COL III, FN, COL I and MMP-9 at mRNA and protein levels in tendon biopsies. FGF gene expression associated positively with improved total ATRS and better functional outcomes. Additionally, FGF mRNA levels were associated with less pain, less running limitations and less loss in physical activity. In addition, higher COL III mRNA expression was associated with more tendon strength. Conclusion Our findings indicate that FGF gene expression is associated with improved patient-reported outcome. FGF expression in surgical biopsies could potentially be used to assist the prognostic evaluation of patient outcome and may be used as a predictor for healing. However, further studies are needed to evaluate the role of FGF in Achilles tendon healing. Level of evidence II